Post COVID-19 Arterial Thromboembolism: A Clear and Present Danger
Bingwen Eugene Fan, Christine Cheung
Abstract
While an increased incidence of thromboembolic events and hypercoagulability during acute SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection has been well described,[1] [2] arterial thrombosis post COVID-19 (coronavirus disease 2019), although uncommon, has yet to be recognized as part of the late sequelae of COVID-19 (i.e., "long COVID") by the Centers for Disease Control and Prevention (CDC) in their guidance of "Late Sequelae of COVID-19" under the Clinical Care Guidance for Healthcare Professionals about Coronavirus (COVID-19),[3] or by the National Institute for Health and Care Excellence (NICE) in recently published living guidelines on post–acute COVID-19.[4] This is, despite the emerging reports of post COVID-19 arterial thrombosis, particularly in patients without cardiovascular risk factors.[5] [6] [7] [8] [9]